The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
risedronate sodium · RISEDRONATE SODIUM HEMI-PENTAHYDRATE 75 mg/1 · Tablet, Film Coated · Oral · Sun Pharmaceutical Industries, Inc.
NDC 47335-0727-98 · 1 BLISTER PACK in 1 CARTON / 2 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | RISEDRONATE SODIUM 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | RISEDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | RISEDRONATE SODIUM 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | RISEDRONATE SODIUM 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pel Healthcare Llc | RISEDRONATE SODIUM MONOHYDRATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | RISEDRONATE SODIUM MONOHYDRATE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | RISEDRONATE SODIUM MONOHYDRATE 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | RISEDRONATE SODIUM MONOHYDRATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 30 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "risedronate sodium — NDC 47335-0727-98," retrieved September 3, 2026, https://drugdashboards.com/drug/47335072798.
Free to cite with attribution — see how the data is put together.